Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis

被引：0
|
作者：
Perera, G. [1 ]
Fonia, A. [1 ]
Smith, C. [1 ]
Barker, J. N. W. N. [1 ]
机构：
[1] St Johns Inst Dermatol, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2009年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of etanercept in moderate to severe plaque psoriasis using two different dosing regimens
    Mazzotta, A
    Costanzo, A
    Giunta, A
    Chimenti, S
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB201 - AB201
  • [42] Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis
    Cather, Jennifer Clay
    Young, Chaney T.
    Young, Melody S.
    Cather, J. Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (08) : 983 - 990
  • [43] Etanercept and methotrexate combination therapy for the treatment of moderate to severe psoriasis: A retrospective multicentre study
    Munoz-Santos, Carlos
    Vidal, David
    Gomez-Vazquez, Mercedes
    Sola-Ortigosa, Joaquim
    Guilabert, Antonio
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 (04) : E147 - E148
  • [44] ABT-874 versus etanercept and placebo in patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results
    Strober, Bruce
    Crowley, Jeffrey
    Valdes, Joaquin
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
  • [45] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [46] Pharmacogenetics of ustekinumab in patients with moderate-to-severe plaque psoriasis
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Cabaleiro, Teresa
    Solano-Lopez, Guillermo
    Marquez, Beatriz
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (02) : 157 - 164
  • [47] The experience of pain and redness in patients with moderate to severe plaque psoriasis
    Martin, Mona L.
    Gordon, Kenneth
    Pinto, Lionel
    Bushnell, Donald M.
    Chau, Dina
    Viswanathan, Hema N.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2015, 26 (05) : 401 - 405
  • [48] Assessment of Cardiovascular Risk in Patients With Moderate to Severe Plaque Psoriasis
    Fernandez-Llaca, Hector
    de la Cueva, Pablo
    Luelmo, Jesus
    Carlos Armario-Hita, Jose
    Luz Samaniego, M.
    Garcia-Calvo, Carmen
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (10) : 1240 - 1247
  • [49] PSYCHOMETRIC EVALUATION OF THE PSORIASIS SYMPTOMS SCALE IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Armstrong, A. W.
    Edson-Heredia, E.
    Naegeli, A. N.
    Sun, L.
    Zhu, B.
    Wyrwich, K. W.
    VALUE IN HEALTH, 2018, 21 : S241 - S242
  • [50] Patient choice of dosing frequency among moderate-to-severe plaque psoriasis patients with adalimumab, etanercept, and/or ustekinumab experience
    Carter, Chureen
    Farahi, Kamyar
    Johnson, Michael P.
    Olson, William
    Zhang, Mingliang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB262 - AB262
12345